With AbbVie-Allergan decision, Simons draws the line, blasts Dems

Monday, May 18, 2020 @ 10:30 AM

Perhaps more than in any other case since Joe Simons became chairman of the Federal Trade Commission, the 3-2 decision approving drugmaker AbbVie’s $63 billion buyout of rival Allergan reveals his unhappiness with the dissents of his Democratic colleagues. ... [read more]